Introduction
One of the current directions in contraceptive vaccine development implies immunological inter¬ ference with fertilization using antibodies directed to the zona pellucida, an acellular glycoprotein coat surrounding the ovulated oocyte (for review see Henderson et ai, 1988) . Passive immunization ofmice (Sacco, 1979; Aitken et ai, 1981 ;Tsunoda<?/a/., 1981) and rats (East et ai, 1984 (East et ai, ,1985 with antibodies to the zona pellucida produced reversible contraception by preventing zona penetration by spermato¬ zoa without obvious side effects. However, active immunization with zona pellucida antigens has been repeatedly reported to result in considerable ovarian histopathology and dysfunction in various mammalian species (Wood et ai, 1981; Mahi-Browneía/., 1982 ,1985 Gulyas et ai, 1983; Sacco et ai, 1983 Sacco et ai, ,1987 Skinner et ai, 1984) .
Recent observations on multiple roles of the cumulus oophorus, another component of the extracellular coat surrounding the ovulated oocyte, in fertilization (Tesarik et ai, 1988 (Tesarik et ai, , 1990a Siiteri et ai, 1988; Meizel et ai, 1990 ; for review see Tesarik & Testart, 1989) and the demonstrated inhibition of human fertilization in vitro by antibodies to the human cumulus intercellular matrix (Tesarik, 1989) have prompted us to adopt an alternative strategy for contraceptive vaccine devel¬ opment, implicating cumulus antigens as antibody targets. This approach is based on the reasoning that antibodies to components of the extracellular matrix of the human cumulus oophorus, a secretory product of cumulus cells which appears late in preovulatory development, will probably confine the antibody action to only one preovulatory follicle in each cycle, unlike antibodies to the zona pellucida that develops early in folliculogenesis.
Before examination of the anti-cumulus antibody action in active immunization experiments, we analysed the effects of passive immunization of anti-cumulus antibodies on fertility in mice and found a reversible inhibition of fertility after a single antibody administration (Tesarik et ai, 1990b) . The present study was undertaken to examine the effects of prolonged passive immuniza¬ tion with anti-cumulus antibodies on the sexual and reproductive functions, including the possible effects on the ovarian oocyte pool. (Fig. 1) .
In Exp. 1, anti-cumulus Ig (0-5 mg) was administered 3 times at 2-week intervals. The injected females were caged with males for 4 consecutive days preceding the last antibody injection and examined for the presence of copulatory vaginal plugs during this period. This procedure was repeated twice at 2-week intervals while 0-5 mg non-specific rabbit immunoglobulin (Sigma, La Verpilière, France) was injected instead of anti-cumulus Ig (Fig. 1 ). The number of pregnant females after the first fertile mating period and the resulting litter size for each pregnant female were recorded. The animals were killed immediately after parturition and their ovaries were processed for histological examination ( Fig. 1) .
In Exp. 2, anti-cumulus Ig was substituted in the third injection with 0-5 mg non-specific rabbit immunoglobulin (Sigma). Control mice were given repeated injections of 0-5 mg non-specific rabbit immunoglobulin only ( Fig. 1 ). Healthy and atretic follicles were distinguished in all these categories using common histological criteria of follicular atresia (degeneration ofthe oocyte, high incidence of nuclear pycnosis in granulosa cells, cellular debris in the follicu¬ lar cavity). Oocytes contained in different types of follicles were counted for each ovary in the largest-diameter section 
Results
The administration of 0-5 mg anti-cumulus Ig repeated at 2-week intervals resulted in complete inhibition of fertility in the injected females throughout the treatment (Table 1) . At the same time, there was no apparent effect of this treatment on the sexual activity as judged from daily assess¬ ments of vaginal plugs during the period for which the females were caged with males (Table 1) . When anti-cumulus Ig was replaced with non-specific immunoglobulin at the third (Exp. 2) or fourth (Exp. 1) injection (Fig. 1) , fertility was restored in 2 weeks. In both experimental groups, term pregnancies were achieved and the number of offspring resulting from them was not different from controls (Table 1) .
The qualitative histological examination of ovaries taken from females after the young had been born did not reveal any apparent alteration of ovarian structure. In quantitative terms, oocytes contained in primordial and growing non-antral follicles were represented equally in both experimental groups and did not differ from controls. However, there was a slight but significant increase in the number of antral-follicle oocytes in the two experimental groups compared with controls (Fig. 2a) . This increase was due to a higher proportion of atretic antral follicles in the antibody-treated animals (Fig. 2b) . In other words, ovaries of the antibody-treated and control animals contained equal numbers of oocytes in healthy antral follicles but, in addition to them, the treated animals had elevated numbers of oocytes in antral follicles showing signs of atresia. In contrast, no increase in follicular atresia due to anti-cumulus Ig treatment was observed for primordial and growing non-antral follicles (Fig. 2b ).
Discussion
The experiments described here were undertaken as a prelude to an active immunization study, to determine whether prolonged action of anti-cumulus oophorus antibodies administered at a dose sufficient to block fertility completely produces any detectable side-effects concerning the functional integrity ofthe reproductive system. The persistence of complete fertility inhibition throughout the treatment is proof of the maintenance of contraceptive levels of anti-cumulus antibodies in the immunized animals between individual antibody applications.
No changes in the sexual behaviour of antibody-treated mice were observed compared with controls. This implies the absence of serious hormonal disturbances which would be incompatible with the normal oestrous cycle. The possibility of oestrus under the conditions of prolonged anticumulus antibody action was doubted because of the considerable decrease in the number of ovulated eggs after a single antibody injection applied to mice on the day of PMSG treatment in the superovulation regimen; this decrease was apparently due to interference of anti-cumulus anti¬ bodies with the final phases of preovulatory follicular development (Tesarik et ai, 1990b) . How¬ ever, in that study, the anti-cumulus oophorus antibodies bound preferentially to cumulus-oocyte complexes and not to mural granulosa cells or to other ovarian structures. Preovulatory follicles may therefore continue virtually normal steroid production under the action of anti-cumulus antibodies even if they are not able to produce and release normal mature eggs.
Reversibility ofthe anti-cumulus antibody effect on the reproductive performance in mice after a single administration has been described previously (Tesarik et ai, 1990b) . In this study we were unable to demonstrate any persistent impairment of fertility when the treatment was stopped after maintaining contraceptive levels of circulating antibodies for as long as 6 weeks. Unlike anti-zona pellucida antibodies, which firmly bind to the zona pellucida of ovarian oocytes that have not yet been recruited from the quiescent oocyte pool and consequently produce prolonged infertility even after a single antibody administration (Tsunoda & Sugie, 1977; Sacco, 1979) , purified anti-cumulus antibodies are only retained in the cumulus-oocyte complex of large preovulatory follicles (Tesarik et ai, 1990b) . Therefore, all preovulatory follicles that develop after the elimination of circulating antibodies are very probably antibody-free. This might explain the relatively rapid restoration of fertility after the cessation of anti-cumulus antibody administration observed in the present study.
The evaluation of ovarian histology did not show any changes in the structure and quantitative representation of primordial and growing preantral follicles which could be ascribed to the anticumulus antibody action. However, there was a slight increase in the number of antral follicles in the antibody-treated animals and this increase was due to a higher incidence of atresia in this follicular category. Since the ovaries for histological examination were taken from animals whose fertility had been completely restored after the cessation of anti-cumulus antibody treatment, this isolated increase in follicular atresia concerning specifically antral follicles was clearly due to a rather remote previous antibody effect on ovarian follicular development. As it has been shown that anti-cumulus antibodies reduce the ovulation rate by an effect that is limited to large antral follicles (Tesarik et ai, 1990b) 
